GL1X · GenesisL1 explorer

MolNFT v1 · #52729 · protein

Wild-type staphylococcus aureus DHFR in complex with NADPH and trimethoprim

2W9G · Dihydrofolate reductase: “Wild-type staphylococcus aureus DHFR in complex with NADPH and trimethoprim”. X-ray diffraction, 2 ligands (TOP, NDP), 1 pocket (best druggability 0.69). MolNFT v1 #52729 on GenesisL1: 3D structure, binding…

PDB
2W9G
Type
protein
Length
157 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydrofolate reductase
EC
1.5.1.3
UniProt
P0A017
Ligands
TOP, NDP
Pockets
1 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 20% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydrofolate reductase (EC 1.5.1.3)protein15720% helix, 36% strandP0A017

Ligands and binding sites

  • TOP · Trimethoprim · ligand · chains A
  • NDP · Nadph dihydro-nicotinamide-adenine-dinucleotide phosphate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13380.690.8236TOP, NDP

Compared structures

  • 2W9G · Wild-type Staphylococcus aureus DHFR in complex with NADPH and trimethoprim · the same entry in another collection · chain A against A, TM-score 1.00
  • P0A017 · AlphaFold monomer V2.0 prediction for dihydrofolate reductase (P0A017) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.